StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research note released on Wednesday morning. The brokerage issued a sell rating on the stock.
SenesTech Stock Up 4.8 %
Shares of NASDAQ SNES opened at $2.39 on Wednesday. SenesTech has a 12-month low of $1.90 and a 12-month high of $53.28. The company has a debt-to-equity ratio of 0.05, a quick ratio of 3.49 and a current ratio of 4.68. The firm has a 50 day moving average of $3.12 and a 200 day moving average of $5.30.
SenesTech (NASDAQ:SNES – Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($3.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($3.20) by $0.12. SenesTech had a negative net margin of 464.09% and a negative return on equity of 168.64%. The firm had revenue of $0.46 million during the quarter, compared to the consensus estimate of $0.49 million. During the same quarter in the previous year, the firm posted ($84.03) EPS. Sell-side analysts expect that SenesTech will post -11 earnings per share for the current fiscal year.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
See Also
- Five stocks we like better than SenesTech
- The 3 Best Retail Stocks to Shop for in August
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- Which Wall Street Analysts are the Most Accurate?
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Where to Find Earnings Call Transcripts
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
